Back to Deals
Value £11,500,000
Summary
Syndex Bio has secured £11.5 million in Seed funding led by ARCH Venture Partners.
Summary of transaction details:
- Value: £11.5 million
- Sector: Healthcare & Biotech
- Advisor: N/A
- Key Entities: Syndex Bio, ARCH Venture Partners
- Location: Cambridge, UK
Note: This investment will enable Syndex Bio to further develop its proprietary mcPCR platform, advancing next-generation molecular diagnostics.
Lead Investor / Acquirer
ARCH Venture Partners
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
View the original press release or news article describing this transaction in full.
Read Original PostAI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in